103 related articles for article (PubMed ID: 12531698)
1. Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells.
Ewald JA; Wilkinson JC; Guyer CA; Staros JV
Exp Cell Res; 2003 Jan; 282(2):121-31. PubMed ID: 12531698
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
[TBL] [Abstract][Full Text] [Related]
3. Real-time kinetics of ligand/cell surface receptor interactions in living cells: binding of epidermal growth factor to the epidermal growth factor receptor.
Wilkinson JC; Stein RA; Guyer CA; Beechem JM; Staros JV
Biochemistry; 2001 Aug; 40(34):10230-42. PubMed ID: 11513601
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells.
Pierce JH; Ruggiero M; Fleming TP; Di Fiore PP; Greenberger JS; Varticovski L; Schlessinger J; Rovera G; Aaronson SA
Science; 1988 Feb; 239(4840):628-31. PubMed ID: 3257584
[TBL] [Abstract][Full Text] [Related]
9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling.
Högnason T; Chatterjee S; Vartanian T; Ratan RR; Ernewein KM; Habib AA
FEBS Lett; 2001 Feb; 491(1-2):9-15. PubMed ID: 11226409
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
14. Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3.
Teller S; Krämer D; Böhmer SA; Tse KF; Small D; Mahboobi S; Wallrapp C; Beckers T; Kratz-Albers K; Schwäble J; Serve H; Böhmer FD
Leukemia; 2002 Aug; 16(8):1528-34. PubMed ID: 12145694
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal.
Li W; Zhang J; Flechner L; Hyun T; Yam A; Franke TF; Pierce JH
Oncogene; 1999 Nov; 18(47):6564-72. PubMed ID: 10597260
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
[TBL] [Abstract][Full Text] [Related]
17. EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line.
Treda C; Popeda M; Ksiazkiewicz M; Grzela DP; Walczak MP; Banaszczyk M; Peciak J; Stoczynska-Fidelus E; Rieske P
PLoS One; 2016; 11(5):e0155230. PubMed ID: 27153109
[TBL] [Abstract][Full Text] [Related]
18. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
Danielsen AJ; Maihle NJ
Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand.
Zhu HJ; Iaria J; Orchard S; Walker F; Burgess AW
Growth Factors; 2003 Mar; 21(1):15-30. PubMed ID: 12795333
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
